Didanosine Resistance in HIV-infected Patients Switched from Zidovudine to Didanosine Monotherapy
Tags: ANTIVIRAL agents; REVERSE transcriptase
Related Articles
- Liver toxicity induced by non-nucleoside reverse transcriptase inhibitors. Antonio Rivero; Jos� A. Mira; Juan A. Pineda // Journal of Antimicrobial Chemotherapy (JAC);Mar2007, Vol. 59 Issue 3, p342
Liver toxicity is one of the most relevant adverse effects of antiretroviral therapy. Within the non-nucleoside reverse transcriptase inhibitors (NNRTIs), efavirenz can be considered a safer drug for the liver than nevirapine. In fact, the frequency of severe increased liver enzymes in patients...
- A New Cell-Selective Three-Dimensional Microincubator Based on Silicon Photonic Crystals. Scherrer, Alexandra U.; Böni, Jürg; Yerly, Sabine; Klimkait, Thomas; Aubert, Vincent; Furrer, Hansjakob; Calmy, Alexandra; Cavassini, Matthias; Elzi, Luigia; Vernazza, Pietro L.; Bernasconi, Enos; Ledergerber, Bruno; Günthard, Huldrych F. // PLoS ONE;Nov2012, Vol. 7 Issue 11, Special section p1
In this work, we show that vertical, high aspect-ratio (HAR) photonic crystals (PhCs), consisting of periodic arrays of 5 µm wide gaps with depth of 50 µm separated by 3 µm thick silicon walls, fabricated by electrochemical micromachining, can be used as three-dimensional microincubators,...
- Pharmacology of Current and Investigational Human Immunodeficiency virus (HIV) Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Adults. Laura Waters; Marta Boffito // Anti-Infective Agents in Medicinal Chemistry;2007, Vol. 6 Issue 3, p213
Since the mid-1980s, the nucleoside reverse transcriptase inhibitors (NRTIs) have established their position as valuable antiretroviral (ARV) agents in the treatment of human immunodeficiency virus (HIV) infection. Today, NRTIs still constitute the �backbone� of highly active ARV therapy...
- Mutations in HIV-1 Reverse Transcriptase Potentially Associated with Hypersusceptibility to Nonnucleoside Reverse-Transcriptase Inhibitors: Effect on Response to Efavirenz-Based Therapy in an Urban Observational Cohort. Tozzi, Valerio; Zaccarelli, Mauro; Narciso, Pasquale; Trotta, Maria Paola; Ceecherini-silberstein, Francesca; De Longis, Patrizio; D'offizi, Giampiero; Forbici, Federica; D'arrigo, Roberta; Boumis, Evangelo; Bellagamba, Rita; Bonfigli, Sandro; Carvelli, Chiarina; Antinori, Andrea; Federico Perno, Carlo // Journal of Infectious Diseases;5/1/2004, Vol. 189 Issue 9, p1688
Background. Hypersusceptibility to nonnucleoside reverse-transcriptase inhibitors (NNRTIs) was described in association with reverse-transcriptase (RT) mutations conferring resistance to nucleoside reverse-transcriptase inhibitors (NRTIs). We evaluated the effect of RT mutations associated with...
- Characterization of the Mechanism of Zidovudine Uptake by Rat Conditionally Immortalized Syncytiotrophoblast Cell Line TR-TBT. Y. Sai; T. Nishimura; S. Shimpo; T. Chishu; K. Sato; N. Kose; C. Mukai; S. Kitagaki; N. Miyakoshi; Y.-S. Kang; E. Nakashima // Pharmaceutical Research;Jul2008, Vol. 25 Issue 7, p1647
Abstract Purpose��To characterize the uptake mechanism of zidovudine (AZT), a nucleoside reverse transcriptase inhibitor, in syncytiotrophoblast cells using the TR-TBT 18d-1 cell line previously established by our group. Materials and Methods��The effects of several transporter...
- The Influence of Natural Substrates and Inhibitors on the Nucleotide- Dependent Excision Activity of HIV-1 Reverse Transcriptase in the Infected Cell. Smith, Anthony James; Scott, Walter Alvin // Current Pharmaceutical Design;Jun2006, Vol. 12 Issue 15, p1827
Human immunodeficiency virus type 1 resistance to nucleoside reverse transcriptase inhibitors such as 3'- azido-2', 3'-dideoxythymidine (AZT) can arise through mutations in the coding region of reverse transcriptase (RT) that enhance the enzyme's ability to remove the drug after it has been...
- Cellular Interactions of Virion Infectivity Factor (Vif) as Potential Therapeutic Targets: APOBEC3G and More? Carr, J. M.; Davis, A. J.; Feng, F.; Burrell, C. J.; Li, P. // Current Drug Targets;Dec2006, Vol. 7 Issue 12, p1583
Vif is an HIV accessory protein whose primary function is to negate the action of APOBEC3G, a naturally occurring cellular inhibitor of HIV replication. Vif acts by binding to APOBEC3G, inducing its protein degradation within infected cells and reducing its levels in progeny virions....
- Antiretroviral Drug Resistance and Routine Therapy, Cameroon. Laurent, Christian; Kouanfack, Charles; Vergne, Laurence; Tardy, Mich�le; Zekeng, L�opold; Noumsi, Nathalie; Butel, Christelle; Bourgeois, Anke; Mpoudi-Ngol�, Eitel; Koulla-Shiro, Sinata; Peeters, Martine; Delaporte, Eric // Emerging Infectious Diseases;Jun2006, Vol. 12 Issue 6, p1001
Among 128 patients routinely receiving highly active antiretroviral therapy in an HIV/AIDS outpatient clinic in Cameroon, 16.4% had drug resistance after a median of 10 months. Of these, 12.5% had resistance to nucleoside reverse transcriptase inhibitors (NRTIs), 10.2% to non- NRTIs, and 2.3% to...
- OPTIMAL CONTROL OF COMBINED THERAPY IN A SINGLE STRAIN HIV-1 MODEL. Garira, Winston; Musekwa, Senelani D.; Shiri, Tinevimbo // Electronic Journal of Differential Equations;2005, Vol. 2005, p1
Highly active antiretroviral therapy (HAART) is administered to symptomatic human immunodeficiency virus (HIV) infected individuals to improve their health. Various administration schemes are used to improve patients' lives and at the same time suppressing development of drug resistance, reduce...
